Kalina U - Search Results

1

Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.

Pabinger I, Tiede A, Kalina U, Knaub S, Germann R, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group. Pabinger I, et al. Among authors: kalina u. Ann Hematol. 2010 Mar;89(3):309-16. doi: 10.1007/s00277-009-0830-7. Epub 2009 Sep 29. Ann Hematol. 2010. PMID: 19787352 Clinical Trial.

2

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group. Pabinger I, et al. Among authors: kalina u. J Thromb Haemost. 2008 Apr;6(4):622-31. doi: 10.1111/j.1538-7836.2008.02904.x. Epub 2008 Jan 15. J Thromb Haemost. 2008. PMID: 18208533 Free article. Clinical Trial.

3

Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers.

Ostermann H, Haertel S, Knaub S, Kalina U, Jung K, Pabinger I. Ostermann H, et al. Among authors: kalina u. Thromb Haemost. 2007 Oct;98(4):790-7. Thromb Haemost. 2007. PMID: 17938803

4

Pharmacokinetics and safety of fibrinogen concentrate.

Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P; FIBRINOGEN CONCENTRATE STUDY GROUP. Manco-Johnson MJ, et al. Among authors: kalina u. J Thromb Haemost. 2009 Dec;7(12):2064-9. doi: 10.1111/j.1538-7836.2009.03633.x. Epub 2009 Oct 5. J Thromb Haemost. 2009. PMID: 19804533 Free article. Clinical Trial.

5

Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency.

Kalina U, Stöhr HA, Bickhard H, Knaub S, Siboni SM, Mannucci PM, Peyvandi F. Kalina U, et al. Blood Coagul Fibrinolysis. 2008 Dec;19(8):777-83. doi: 10.1097/MBC.0b013e32830ef90c. Blood Coagul Fibrinolysis. 2008. PMID: 19002044

6

Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.

Hofmann WK, Seipelt G, Ottmann OG, Kalina U, Koschmieder S, Brücher J, Frickhofen N, Klausmann M, Mitrou PS, Hoelzer D. Hofmann WK, et al. Among authors: kalina u. Ann Hematol. 2000 May;79(5):255-8. doi: 10.1007/s002770050589. Ann Hematol. 2000. PMID: 10870480

7

Biochemical comparison of seven commercially available prothrombin complex concentrates.

Kalina U, Bickhard H, Schulte S. Kalina U, et al. Int J Clin Pract. 2008 Oct;62(10):1614-22. doi: 10.1111/j.1742-1241.2008.01859.x. Epub 2008 Aug 7. Int J Clin Pract. 2008. PMID: 18691229

8

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays.

Horn C, Négrier C, Kalina U, Seifert W, Friedman KD. Horn C, et al. Among authors: kalina u. J Thromb Haemost. 2019 Jan;17(1):138-148. doi: 10.1111/jth.14332. Epub 2018 Dec 16. J Thromb Haemost. 2019. PMID: 30418692 Free PMC article.

9

Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.

Hofmann WK, Kalina U, Wagner S, Seipelt G, Ries C, Hoelzer D, Ottmann OG. Hofmann WK, et al. Among authors: kalina u. Exp Hematol. 1999 Mar;27(3):395-400. doi: 10.1016/s0301-472x(98)00077-0. Exp Hematol. 1999. PMID: 10089900 Free article.

10

Megakaryocytic growth in patients with refractory anemia is suppressed by treatment with interferon alpha.

Hofmann WK, Kalina U, Seipelt G, Hoffmann K, Wagner S, Hoelzer D, Ottmann OG. Hofmann WK, et al. Among authors: kalina u. Eur J Haematol. 1999 May;62(5):336-40. doi: 10.1111/j.1600-0609.1999.tb01912.x. Eur J Haematol. 1999. PMID: 10359063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page